BHA (butylated hydroxyanisole) is not banned in Europe. It is, however, heavily restricted in both cosmetics and food. The European Union allows BHA in cosmetic products at concentrations up to 0.07%, and it remains authorized as a food additive under the code E320, with strict limits on which food categories can contain it and at what levels.
The confusion likely stems from the fact that BHA faces much tighter regulation in Europe than in the United States, and it has been flagged by European safety panels for potential endocrine-disrupting properties. Here’s what the actual rules look like.
BHA in European Cosmetics
Under the EU Cosmetics Regulation (EC No 1223/2009), BHA is not listed on Annex II, which is the official list of substances completely prohibited in cosmetic products. Instead, it falls under restricted use. The EU’s Scientific Committee on Consumer Safety (SCCS) evaluated BHA specifically because of concerns about endocrine disruption and concluded that BHA in leave-on and rinse-off cosmetic products is safe up to a maximum concentration of 0.07%.
That’s a notably low ceiling. For comparison, the highest concentrations reported in cosmetic products globally reach about 0.15% in leave-on products like lotions and moisturizers. Rinse-off products like shampoos tend to use even less, with reported maximums around 0.0084%. So while BHA isn’t banned from European skincare and beauty products, the amount allowed is tightly controlled.
One important caveat: the SCCS safety opinion only covers products applied to the skin. It explicitly does not cover oral care products (like toothpaste or mouthwash) or any cosmetic product that could be inhaled, such as spray-on formulations. For those product types, BHA’s safety hasn’t been confirmed by the committee, which effectively limits its practical use even further.
BHA in European Food
BHA is authorized as a food additive in the EU under the designation E320. It functions as a synthetic antioxidant, meaning it prevents fats and oils from going rancid. The European Food Safety Authority (EFSA) re-evaluated BHA’s safety in 2011, building on earlier assessments dating back to 1989 by both the EU’s Scientific Committee for Food and the joint FAO/WHO Expert Committee on Food Additives.
Its use in food is limited to specific categories with defined maximum levels. For instance, BHA is authorized in pre-cooked cereals at up to 200 mg/kg. It can also appear in other processed foods through the “carry-over principle,” meaning if BHA is present in an ingredient (like a fat or oil used during manufacturing), trace amounts may carry over into the finished product. However, the EU restricts even this carry-over for certain food categories, including unemulsified animal and vegetable oils and fats.
So in food, BHA occupies a middle ground: permitted but confined to specific uses rather than broadly allowed as a general-purpose preservative.
Why BHA Gets Flagged for Safety Concerns
The reason BHA attracts so much regulatory attention comes down to two findings. First, the U.S. National Toxicology Program classifies BHA as “reasonably anticipated to be a human carcinogen.” Animal studies have shown that dietary exposure to BHA caused both benign and malignant tumors in the forestomach (a structure found in rodents but not humans) in rats of both sexes, as well as in male mice and hamsters. In fish, larval exposure to BHA led to liver cancer in adulthood.
Second, European regulators have specifically investigated BHA for endocrine-disrupting properties, meaning it may interfere with hormone signaling in the body. This concern prompted the SCCS to conduct its most recent safety review and set the 0.07% concentration limit for cosmetics.
The cancer findings in animals are real but come with context. The forestomach tumors occurred in a digestive structure that humans don’t have, which makes direct translation to human risk uncertain. Still, the combination of cancer signals in multiple animal species and endocrine disruption concerns explains why European regulators treat BHA more cautiously than their American counterparts.
How European and U.S. Rules Differ
The U.S. FDA classifies BHA as “generally recognized as safe” (GRAS) for use as a food preservative, which allows broader use across more food categories. In cosmetics, the U.S. has no equivalent to the EU’s 0.07% concentration cap. American products can contain BHA at higher levels, and reported concentrations in U.S. cosmetics reach up to 0.15%.
This gap in regulation is the root of the “banned in Europe” narrative. BHA isn’t banned, but Europe does apply the precautionary principle more aggressively. Where American regulators set a higher bar for restricting a substance (requiring stronger proof of harm), European regulators are more willing to impose limits based on potential risk, even when the evidence comes primarily from animal studies.
What This Means for Product Labels
If you’re buying cosmetics or food products sold in Europe, BHA may still appear on the ingredient list. Its presence at the low concentrations allowed under EU rules has been deemed safe by the relevant scientific committees. Products imported from outside the EU could technically contain higher concentrations, though any product legally sold within the EU must comply with European limits.
On ingredient labels, look for “butylated hydroxyanisole,” “BHA,” or “E320” in food products. It’s most commonly found in lipsticks, moisturizers, and other products containing fats or oils, as well as in processed foods where it prevents oxidation. If you prefer to avoid it entirely, BHA-free alternatives are widely available, since many manufacturers have already reformulated to meet European standards or to appeal to consumers looking for cleaner ingredient lists.